Trinity Bio ADR (TRIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 43,785 | 61,555 | 56,832 | 62,521 | 92,965 |
| Cost of Goods | 26,898 | 40,114 | 37,382 | 45,253 | 54,888 |
| Gross Profit | 16,887 | 21,441 | 19,450 | 17,268 | 38,077 |
| Operating Expenses | 33,574 | 42,720 | 46,877 | 36,870 | 32,340 |
| Operating Income | -15,789 | -21,165 | -27,045 | -19,349 | 6,625 |
| Interest Expense | 21,388 | 9,565 | 11,053 | 24,734 | 7,097 |
| Other Income | 0 | 0 | 1,171 | 303 | 1,223 |
| Pre-tax Income | -37,177 | -30,730 | -36,927 | -43,780 | 751 |
| Income Tax | 199 | 486 | -59 | -194 | -178 |
| Net Income Continuous | -37,376 | -31,216 | -36,868 | -43,586 | 929 |
| Net Income Discontinuous | N/A | -573 | 12,850 | 2,577 | -54 |
| Net Income | $-37,376 | $-31,789 | $-24,018 | $-41,009 | $875 |
| EPS Basic Total Ops | -2.00 | -1.80 | -15.70 | -30.40 | 1.00 |
| EPS Basic Continuous Ops | -2.01 | -1.74 | -24.08 | -32.30 | 1.06 |
| EPS Basic Discontinuous Ops | N/A | -0.03 | 8.39 | 1.91 | -0.06 |
| EPS Diluted Total Ops | -2.00 | -1.80 | -15.70 | -30.40 | 1.00 |
| EPS Diluted Continuous Ops | -2.01 | -1.74 | -24.08 | -32.30 | 1.06 |
| EPS Diluted Discontinuous Ops | N/A | -0.03 | 8.39 | 1.91 | -0.06 |
| EPS Diluted Before Non-Recurring Items | N/A | -7.35 | -16.85 | -26.25 | 8.75 |
| EBITDA(a) | $-13,105 | $-19,300 | $-25,268 | $-17,016 | $9,369 |